A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis
No Thumbnail Available
Authors
Tan, Rachael J. L.
Ahuja, Anusha
Shrestha, Aakanksha
Gallen, Geraldine
Stotesbury, Ben
Cheah, Yee
Mustafa, Omar G.
Whyte, Martin B.
Croos, Jonathan
Shooshtarian, Adam
Contact
Check for full-text access
Issue Date
2026
Type
Article
Language
Keywords
Alternative Title
Abstract
AIMS: A retrospective observational cohort study evaluating real-world outcomes in adults with type 1 diabetes and gastroparesis using automated hybrid closed loop insulin delivery systems (HCL). MATERIALS AND METHODS: All adults with type 1 diabetes and gastroparesis attending King's College Hospital diabetes service and using continuous glucose monitoring (CGM) from 5 October 2023 to 16 January 2025 were included. Glycaemic data (HbA RESULTS: From 1827 clinic attendees, 36 adults with gastroparesis were identified, with 17 initiating HCL. HCL and non-HCL groups had comparable baseline characteristics and metrics (HCL: Mean(SD) HbA CONCLUSIONS: Within a specialist multidisciplinary team setting, HCL systems significantly reduce HbA
Description
Citation
Publisher
License
Journal
Diabetes, Obesity and Metabolism
Volume
28
Issue
5